Neuren Pharmaceuticals Balance Sheet

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	5.91	3.15	17.09	40.18	36.78	24.19
Short-Term Investments	293.63	219.09	211.45	-	-	-
Cash & Short-Term Investments	299.54	222.24	228.54	40.18	36.78	24.19
Cash Growth	40.51%	-2.76%	468.79%	9.23%	52.07%	74.72%
Accounts Receivable	20.52	172.91	12.8	-	0.01	-
Other Receivables	0.19	2.42	1.61	1.09	1.42	0.76
Receivables	20.71	175.33	14.41	1.09	1.42	0.76
Prepaid Expenses	-	0.4	4.21	1.98	1.84	-
Other Current Assets	-	1.36	-	-	-	-
Total Current Assets	320.25	399.33	247.16	43.25	40.04	24.94
Property, Plant & Equipment	0.03	0.03	0.04	0.02	0.01	0.01
Long-Term Deferred Tax Assets	10.98	10.35	0.77	-	-	-
Total Assets	331.25	409.71	247.97	43.27	40.06	24.95
Accounts Payable	6.66	1.45	0.68	0.26	0.25	0.17
Accrued Expenses	-	1.45	2.74	0.72	0.56	0.59
Current Income Taxes Payable	-	42.87	37.12	-	-	-
Other Current Liabilities	1.26	-	2.23	0.7	-	-
Total Current Liabilities	7.92	45.76	42.76	1.68	0.8	0.75
Pension & Post-Retirement Benefits	0.06	0.04	-	-	-	-
Total Liabilities	7.98	45.8	42.76	1.68	0.8	0.75
Common Stock	127.59	165.27	173.13	167.74	167.58	145.57
Retained Earnings	195.46	180.43	38.39	-118.69	-118.88	-111.08
Comprehensive Income & Other	0.22	18.2	-6.31	-7.46	-9.45	-10.28
Total Common Equity	323.27	363.9	205.21	41.59	39.25	24.2
Shareholders' Equity	323.27	363.9	205.21	41.59	39.25	24.2
Total Liabilities & Equity	331.25	409.71	247.97	43.27	40.06	24.95
Net Cash (Debt)	299.54	222.24	228.54	40.18	36.78	24.19
Net Cash Growth	40.51%	-2.76%	468.79%	9.23%	52.07%	74.72%
Net Cash Per Share	2.31	1.70	1.75	0.31	0.31	0.23
Filing Date Shares Outstanding	124.49	127.01	127.27	125.97	125.97	114.61
Total Common Shares Outstanding	124.49	127.01	127.27	125.97	125.97	114.61
Working Capital	312.32	353.57	204.39	41.57	39.24	24.19
Book Value Per Share	2.60	2.87	1.61	0.33	0.31	0.21
Tangible Book Value	323.27	363.9	205.21	41.59	39.25	24.2
Tangible Book Value Per Share	2.60	2.87	1.61	0.33	0.31	0.21

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.